Company Profile
Fresenius Medical Care Ventures Stock Price, News & Analysis
- Ticker:
- FMS
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Fresenius Medical Care Ventures is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Stock performance
23.70 USD (+1.33%)
Close
Last updated: June 23, 2026 at 00:00
12.73B USD
Market cap
Why the stock is moving
FMS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Fresenius Medical Care Ventures is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Fresenius Medical Care Ventures makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Fresenius Medical Care Ventures trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model
Source: Fresenius Medical Care Ventures
- 02
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
Source: Fresenius Medical Care Ventures
- 03
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
Source: Fresenius Medical Care Ventures
- 04
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
Source: Fresenius Medical Care Ventures
- 05
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
Source: Fresenius Medical Care Ventures
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Fresenius Medical Care Ventures (FMS)?
Fresenius Medical Care Ventures (FMS) most recently closed at 23.70 USD, a +1.33% move versus the previous session.
What is the market cap of Fresenius Medical Care Ventures (FMS)?
Fresenius Medical Care Ventures currently has a market capitalization of 12.73B USD on BioPharmSignal.
What does Fresenius Medical Care Ventures do?
Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
On which exchange is FMS stock listed?
Fresenius Medical Care Ventures (FMS) is associated with NYSE, Headquartered in the United States and listed on NYSE, Fresenius Medical Care Ventures is followed within the medical devices universe for its exposure to procedure trends and reimbursement support., Biotechnology.
What is Fresenius?
Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Which conditions is Fresenius Medical Care Ventures targeting with Fresenius?
Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
What is Medical?
Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
What is Care?
Fresenius Medical Care Ventures is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.